Expert Talk at Medica Innovation Forum 2026
November 18, 2026 | 2:35pm – 2:50pm CET | Hall 11, #J09
Bringing an innovative medical device to market is about far more than developing a great product. Manufacturers must navigate increasing regulatory requirements, accelerate time-to-market, and successfully scale from prototype to commercial production.
In this speaking session at the Medica Innovation Forum, Volker Buchbauer, VP ATS LSS Europe, will share key insights from ATS’ end-to-end automation journey and demonstrate how the early integration of product development, process development, and automation can accelerate commercialization while reducing risk. Through practical examples and lessons learned from real-world medical device projects, attendees will gain valuable perspectives on building scalable manufacturing strategies, avoiding common development pitfalls, and creating a seamless path from innovation to production.
Whether you are a startup, scale-up, or established medical device manufacturer, this session will provide actionable insights into how automation can help turn promising innovations into successful market-ready products.
Host
Volker Buchbauer
Vice President ATS Life Sciences Systems Europe
With more than 20 years of international experience in automation, advanced manufacturing, robotics, and business leadership, he has successfully led complex customer projects, global teams, and large-scale transformation initiatives across highly regulated industries. Today, he is responsible for driving ATS’ Life Sciences business across Europe, helping pharmaceutical and medical device manufacturers accelerate innovation and bring high-quality products to market through intelligent automation.
Location
Messe Düsseldorf
Stockumer Kirchstraße 61
40474 Düsseldorf
Hall 11 – Booth J09
Event Times
November 18, 2026: 2:35pm – 2:50pm CET
BOOK A MEETING
Visit our expert talk and speak to us about how our innovative and turnkey automation solutions can help you get the edge in the market.
LED UV Curing Technology
Unique technology – a new process no competitor can match
ATS Life Sciences’ innovative LED UV curing technology for glass syringe assembly delivers instant, mercury-free adhesive curing while maintaining proven processes and existing adhesives. The solution reduces energy consumption by up to 50%, minimizes heat generation, eliminates warm-up time, and can be seamlessly integrated into both new and existing production lines for output rates of up to 300 ppm.
Glass Syringe Assembly
Flexible Assembly Solutions for Every Production Stage
ATS Life Sciences provides scalable glass syringe assembly solutions from low-volume development to high-speed production up to 250 ppm. Built on proven platform technology and extensive expertise in injectable drug delivery devices, our solutions help manufacturers achieve reliable, compliant, and efficient production.
PharmaScan™ Liquid
Advanced inspection platforms for clear or colored liquids
This system meets FDA requirements for inspecting parenterals, handling up to 600 parts per minute with high-speed inspection that detects particles as small as 50 µm while reducing false rejects. It supports clear and colored liquids, as well as clear and colored containers, including glass and plastic, ensuring batch traceability and compliance with data handling regulations.
PharmaScan™ Lyo
Advanced inspection platforms for lyophilized products
This system offers near 100% accuracy at speeds of up to 425 ppm, processing approximately 60GB of images per minute. Designed for efficiency with a user-friendly interface, it handles multiple tub pitches, reducing changeovers. Built in North America and locally serviced, it’s recommended for lyophilized cakes and accommodates vials from 2R to 30R.
Messe Düsseldorf
Düsseldorf, Germany
November 18, 2026
Contact Us 
Subscribe 
LinkedIn 
Youtube 
